Abstract
Background: Immunosuppressant therapy is essential in the prevention of organ transplant rejection.
Objective: To evaluate the long-term neurodevelopmental outcomes of children following in utero ciclosporin (cyclosporine) exposure after maternal renal transplantation.
Methods: A cohort study with matched controls using a prospectively collected database was conducted to assess neurocognitive and behavioral outcomes using standardized measures. Thirty-nine children exposed in utero to ciclosporin therapy following maternal renal transplantation were assessed (15 single pregnancies, 24 multiple pregnancies) and compared with 38 matched unexposed children. Intelligence, visuomotor abilities, and psychologic adjustment were measured using the Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R), the Beery Developmental Test of Visual-Motor Integration (VMI-4) and the Wide Range Assessment of Visual Motor Abilities (WRAVMA), and the Child Behavior Checklist (CBCL), respectively. Statistical analysis, including regression, was performed to determine the significant predictors for the main outcome, full-scale IQ (FIQ).
Results: There were no significant differences in FIQ, verbal IQ (VIQ), performance IQ (PIQ) or behavioral outcomes between exposed and unexposed children or between single and multiple delivery groups. Thirty-three percent of exposed children were premature versus 0.5% in unexposed controls (p < 0.01). Prematurity was associated with low birthweight, high rates of perinatal complications, and instrumental deliveries. Relative to full-term children, premature, low birthweight children in the ciclosporin-exposed group had significantly lower FIQ and VIQ scores (101.04 vs 111.31 [p = 0.008] and 102.31 vs 113.08 [p = 0.021], respectively). Maternal IQ and socioeconomic status were positive and significant predictors for children’s IQ (p < 0.001 and p = 0.03, respectively). There were no statistically significant differences in exposed children’s IQ who were and were not breastfed.
Conclusion: In this cohort, there was no association between in utero exposure to ciclosporin and long-term neurocognitive and behavioral development in children after maternal renal transplantation. Maternal IQ and socioeconomic status are positive predictors for children’s intelligence. However, maternal renal transplantation and associated co-morbidity is associated with higher rates of premature delivery and consequent poorer neurocognitive and behavioral outcomes. Proper management of maternal morbidity and improved obstetric care may improve the child’s profile.
Similar content being viewed by others
References
Lockwood GM, Ledger WL, Barlow DH. Successful pregnancies outcome in renal transplant patient following in-vitro fertilization. Human Reprod 1995; 10: 1528–31
Muirhead N, Sabharwal AR, Reider MJ, et al. The outcome of pregnancy following renal transplantation: the experience of a single center. Transplant Proc 1992; 54: 429–32
Kozlowska-Boszko B, Korczak G, Wierzbicki P, et al. Pregnancy following renal transplantation: risk to offsprings. Transplant Proc 1997; 29: 262–5
Rieu P, Neyrat N, Hiesse C, et al. Thirty-three pregnancies in a population of 1725 renal transplant patients. Transplant Proc 1997; 29: 2459–60
Touraine JL, Audra Ph, Lefrancois N, et al. Pregnancy in renal transplant patients: 45 case reports. Transplant Proc 1997; 29: 2472–4
Miniero R, Tardivo I, Curtoni ES, et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol 2002; 15(6): 626–32
Lessan-Pezeshki M. Pregnancy after renal transplantation: points to consider. Nephrol Dial Transplant 2002; 17: 703–7
Sgro M, Barozzino T, Mirghani HM, et al. Pregnancy outcome post renal transplantation. Teratology 2002; 65: 5–9
Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2005; 69–83
Yassaee F, Moshiri F. Pregnancy outcome in kidney transplant patients. Urol J 2007; 4(1): 14–7
Sibanda N, Briggs J, Davison JM, et al. Pregnancy after organ transplantation: a report from the UK Transplant Pregnancy Registry. Transplantation 2007; 83(10): 1301–7
Brown PAJ, Grey ES, Whiting PH, et al. Effects of cyclosporine A on fetal development in the rat. Biol Neonate 1985; 48: 172–80
Mason RJ, Thomson AW, Whiting PH, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation 1985; 39: 9–12
Perico N, Detcheva A, Khalil EI, et al. Cyclosporine induced glomerulo-sclerosis: three-dimensional definition of the lesions in a rat model of renal transplant. Kidney Int 1996; 49: 1283–8
Serkova NJ, Christians U, Benet LZ. Review: biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4: 97–107
Wayman MR, Oniscu GC, Forsythe JL, et al. Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy. Transplant Proc 2002; 34(5): 1663–5
Flechner SM, Katz AR, Rogers AJ, et al. The presence of cyclosporine in body tissues and fluids during pregnancy. Am J Kidney Dis 1985; 5: 60–3
de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987; 317: 861–6
Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2004; 103–14
Meyer-Bahlburg HF, Dolezal C, Baker SW, et al. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 2004 Feb; 89(2): 610–4
Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002 Aug; 100(2): 369–77
McCowan LM, Buist RG, North RA, et al. Perinatal morbidity in chronic hypertension. Am J Obstet Gynecol 1994; 171: 410–6
Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986; 67: 517–22
Huizink A, Robles de Medina PG, Mulder EJH, et al. Stress during pregnancy is associated with developmental outcome in infancy. J Child Psychol Psychiatry 2003; 44: 810–8
Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992; 33: 543–61
Murray L, Hipwell A, Hooper R, et al. The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1996; 37: 927–35
Streissguth A, Barr H, Sampson P. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7½ years. Alcohol Clin Exp Res 2006; 14(5): 662–9
Jacobson S, Chiodo LM, Sokol RJ, et al. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics 2002; 109: 815–25
Lozoff B. Perinatal iron deficiency and the developing brain. Pediatr Res 2000; 48: 137–9
Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159: 1889–95
Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258–62
Laslo-Baker D, Barrera M, Knittel-Keren D, et al. Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med 2004; 158(10): 956–61
Wechsler D. Manual for the Wechsler preschool and primary scale of intelligence. New York: The Psychological Corporation, 1989
Beery K. The Beery-Buktenica developmental test of visual-motor integration: manual. Parsippany (NJ): Modern Curriculum Press, 1997
Adams W, Sheslow D. Wide range assessment of visual motor abilities. Wilmington (DE): Wide Range Inc., 1995
Achenbach TM. Manual for the child behavior checklist/4-18 and 1991 profile. Burlington (VT): Burlington University of Vermont, Department of Psychiatry, 1991
Wechsler D. Wechsler abbreviated scale of intelligence. San Antonio (TX): The Psychological Corporation, 1999
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401
Hollingshead AB. Four factor index of social status. New Haven (CT): Yale University, Department of Sociology, 1975
StataCorp LP. Stata statistical software: release 10. College Station (TX): StataCorp LP, 2007
Beckman C, Ling F, Smith R, et al. “Fetal growth abnormalities” in obstetrics and gynecology. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2006
del Mar Colon M, Hibbard JU. Obstetric considerations in the management of pregnancy in kidney transplant recipients. Adv Chronic Kidney Dis 2007; 14L: 168–77
Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis 2007; 14: 178–90
Ducarme G, Ceccaldi PF, Toupance O, et al. Pregnancy after renal transplantation: obstetrical follow-up and impact on renal graft function. Gynecol Obstet Fertil 2006; 3: 209–13
Cyganek A, Wiczyńska-Zajac A, Jabiry-Zieniewicz Z, et al. Pregnancy delivery and newborn in female kidney recipients. Ginekol Pol 2001; 72: 1287–90
Szymonowicz W, Yu VY. Severe pre-eclempsia and infants of very low birthweight. Arch Dis Child 1987 Jul; 62(7): 712–6
Marlow N, Wolke D, Bracewell MA, et al. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005 Jan 6; 352(1): 9–19
Stanley CQ, Gottleib R, Zager R, et al. Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. Transplant Proc 1999; 31: 241–2
Shaheen F, Al-Sulaiman M, Al-Khader A. Long term nephrotoxicity after exposure to cyclosporine in utero. Transplantation 1992; 56: 224–5
Giudice P, Dubourg L, Hadj-Aissa A, et al. Renal function of children exposed to cyclosporin in utero. Nephrol Dial Transplant 2000; 15: 1575–9
Di Paolo S, Schena A, Morrone LF, et al. Immunological evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipient. Transplantation 2000; 69: 2049–54
Tendron A, Gouyon J, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002; 17: 121–30
Davison JM. Dialysis, transplantation and pregnancy. Am J Kidney Dis 1991; 17: 127–32
Thomas AG, Burrows L, Knight R, et al. The effect of pregnancy on cyclosporine levels in renal allograft patients. Obstet Gynecol 1997; 90: 916–9
McKay DB, Josephson MA. Pregnancy in recipients of solid organs: effects on mother and child. N Engl J Med 2006; 354: 1281–93
Armenti VT, Ahlswede BA, Carter JR, et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney recipients. Transplantation 1995; 59: 476–9
Fischer MJ, Lehnerz SD, Hebert JR, et al. Kidney disease is an independent risk factor for adverse fetal and mental outcomes in pregnancy. Am J Kidney Dis 2004; 43: 415–23
Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis 2007; 14: 132–45
Kuvacic I, Sprem M, Skrablin S, et al. Pregnancy outcome in renal transplant recipients. Int J Gynaecol Obstet 2000; 70(3): 313–7
Acknowledgments
This study was financially supported by the Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation, Hospital for Sick Children, Toronto, Ontario, Canada, and Novartis, Global Epidemiology, Barcelona, Spain. The authors have no conflicts of interest to declare that are directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nulman, I., Sgro, M., Barrera, M. et al. Long-Term Neurodevelopment of Children Exposed In Utero to Ciclosporin After Maternal Renal Transplant. Pediatr-Drugs 12, 113–122 (2010). https://doi.org/10.2165/11316280-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11316280-000000000-00000